Suchbegriffe: SARCOMA - IMMUNOLOGY , . Treffer: 4
Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Absenger, G; Stotz, M; Friesenbichler, J; Trajanoski, S; Stojakovic, T; Eberhard, K; Leithner, A; Pichler, M
The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas.
Int J Cancer. 2014; 135(2):362-370
Doi: 10.1002/ijc.28677
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Gattenlöhner, S; Jörissen, H; Huhn, M; Vincent, A; Beeson, D; Tzartos, S; Mamalaki, A; Etschmann, B; Muller-Hermelink, HK; Koscielniak, E; Barth, S; Marx, A
A human recombinant autoantibody-based immunotoxin specific for the fetal acetylcholine receptor inhibits rhabdomyosarcoma growth in vitro and in a murine transplantation model.
J Biomed Biotechnol. 2010; 2010(8):187621-187621
Doi: 10.1155/2010/187621
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Gattenlohner, S; Marx, A; Markfort, B; Pscherer, S; Landmeier, S; Juergens, H; Muller-Hermelink, HK; Matthews, I; Beeson, D; Vincent, A; Rossig, C
Rhabdomyosarcoma lysis by T cells expressing a human autoantibody-based chimeric receptor targeting the fetal acetylcholine receptor.
Cancer Res. 2006; 66(1):24-28
Doi: 10.1158/0008-5472.CAN-05-0542
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Trieb, K; Lechleitner, T; Lang, S; Windhager, R; Kotz, R; Dirnhofer, S
Evaluation of HLA-DR expression and T-lymphocyte infiltration in osteosarcoma.
Pathol Res Pract. 1998; 194(10):679-684
Doi: 10.1016/S0344-0338(98)80126-X
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar